The effects of a soluble NSP (fibre) concentrate (SFC) on plasma fibrinogen and plasminogen activator inhibitor-1 (PAI-1), serum and liver lipids and lipoproteins and glucose tolerance were compared with those of bezafibrate (BF), a lipid-lowering drug, in obese baboons (Pupio ursinus). The basal diet was a high-fat (37% of total energy), low-NSP (12.4gld) Westernized diet, supplemented for 8 weeks with either 20 SFCghaboon per d or 6.7 mg BFkg body weight per baboon per d. SFC supplementation significantly lowered PAI-1, total serum cholesterol, HDLcholesterol and circulating free fatty acid levels. BF significantly lowered total serum cholesterol, but unexpectedly raised serum triacylglycerol levels. Although not statistically significant, the mean liver tricacylglycerol concentration of baboons fed on BF was lower than that of baboons fed on SFC supplements. These results suggest that: (1) the mechanism of action of the two cholesterol-lowering treatments differ, with BF having a liver triacylglycerol-lowering effect and (2) the SFC had additional beneficial effect on fibrinolysis by lowering PAL1 levels.
Cardiovascular disease accounts for approximately one in every three deaths in Western societies. Increased plasma concentrations of cholesterol, fibrinogen (Wilhemsen et al. 1984; Meade et al. 1986; Kannel et al. 1987) , tissue plasminogen activator inhibitor (PAI-1; Hamsten et al. 1985; Juhan-Vague et al. 1989 ) and insulin (Fontbonne & Eschwege, 1987) are independent risk markers of arterial disease. In human subjects as well as nonhuman primates, abnormalities in haemostasis and carbohydrate and lipid metabolism are often present in the same individual and commonly associated with android (central) obesity (Reaven, 1988; Landin et al. 1990a; Bodkin et al. 1993) . Genetic as well as environmental factors such as diet and physical activity seem to play a role in the development of these disturbances.
Patients under free-living conditions often find it difficult to comply with diet regimens. Therefore, supplementing the diet of human subjects and experimental animals with NSP concentrates such as konjac-glucomannan (KGM), guar gum or oat husk has been tested and reported to be effective in lowering serum total cholesterol (TC; Vorster et al. 1985; Venter et al. 1987; Avrill & Boden, 1995) , improving glucose tolerance (Jenkins et al. 1980; Vorster & de Jager, 1984; Vorster et al. 1988) , lowering plasma fibrinogen (Koepp & Hegewisch, 1981; Vorster et al. 1985; Venter et al. 1991) and PAI-1 activity (Sundell & Rinby, 1993; Brown et al. 1995) .
Treatment with hypolipidaemic drugs is frequently prescribed to patients who do not respond adequately to dietary recommendations. Among such drugs, fibrates have been widely used for many years. Bezafibrate (BF), one of the new derivatives of clofibrate, is a well-tolerated drug with effective hypolipidaemic properties and has the ability to lower raised plasma fibrinogen (Stahlberg, 1992) . Fibrate treatment reduces PAI-1 levels in hypertriacylgl ycerolaemic patients in whom triac ylglycerol (TAG) levels are normalized (Keber et al. 1994) .
The objective of the present investigation was to compare, under controlled conditions of dietary intakes, the effects of a Westernized diet supplemented with a soluble-fibre concentrate (SFC) and BF on plasma haemostatic variables, serum lipid profile, liver lipid content, glucose tolerance and immunoreactive insulin response in the baboon (Pupio ursinus) model. The SFC granules used in the present study contained 600g KGM and 400 g other soluble NSP (pectin and agar)/kg, produced by the Tsuruta Shokuhin Company of Japan and distributed by the Mannan Life Company (Birchacres Pharmacy, Kempton Park, South Africa). KGM is a highly-viscous hemicellulose which consists of a linear polymer of mannose and glucose. According to Southgate (1976) the mannose: glucose value is between 1: 1 and 2.4: 1. It is obtained from the tubers of Amorphophullus konjac (K. Koch) and has been used in Japan for centuries in the form of Konnyako (Ebihara et al. 1981) .
MATERIALS AND METHODS

Animals, experimental design and diets
Twenty healthy adult male baboons weighing 24.1 (SD 3.2) kg were studied. All procedures were approved by the Ethics Committee of the Potchefstroom University. The baboons were caged individually in our laboratory animal centre, allowed to stablize for 8 weeks, treated for internal parasites with IvomectumB (Logosagved, Halfway House, Johannesburg, South Africa; 1 mV50 kg), fed one orange daily and ad libitum a non-purified diet designed for horses (Excella@; Senwesco, Viljoenskroon, South Africa). The baboons had free access to tap water. For the next 8 weeks the baboons were fed on a Westernized diet consisting of 200 g white-bread sandwiches with 20 g margarine (Flora@; Vandenberg Foods (Pty) Ltd, Durban, South Africa), 20g s rup (1110~0~'; CG Smith Sugar Ltd, Natal, South Africa), 40 g peanut butter (Yum-Yum&; Premier Food Industries Ltd, Killarney, South Africa), 80 g shortbread (Eet-Sum-Mar@; Bakers Ltd, Pinetown, South Africa), 30 g plain chocolate (Nest16 SA (Pty) Ltd, Randburg, South Africa), lOOg dog biscuits (Brakenjan@ no. V9796; Senwesco) and 80g fruit (orange and apple). The nutrient analysis was done by computer using local food tables (Langenhoven et al. 1991) . Carbohydrates supplied 51% of the total energy of the diet, protein 12% and fat 37%.
The baboons were then randomly assigned to two groups of ten each, and baseline measurements were taken. The mean weight of the baboons differed significantly from the pre-study weight and both groups were considered as obese (Table 1 ). An increase in waist : hip as well as significant increases in subscapular skinfolds indicated android obesity. For the next 8 weeks group 1 was fed on bezafibrate (6.7 mgkg body weight per baboon per d; BF Bezalip Retard@; Boehringer Mannheim, Mannheim, Germany) and the Westemized diet described previously. Group 2 was fed on the same diet plus 20 g soluble NSP concentrate (Mannan Life dietary fibre; Mannan Life Company) per baboon perd. The NSP supplement and crushed BF tablets were mixed with the margarine, syrup and peanut butter and spread onto the bread. Food intake was recorded every second day. The nutrient composition of the food consumed by the two groups is indicated in Table 2 . After 8 weeks, final measurements were taken before the baboons were killed.
Blood and liver samples
The 2 h glucose tolerance tests (GTT) were performed at baseline and after 8 weeks of hypolipidaemic treatment. The baboons were fasted for 12 h before the GTT were done. All the tests were performed between 08.00 and 11.00 hours in the laboratory animal centre. The baboons were immobilized with ketamine (1 mg/kg body weight; Kyron Laboratories (Pty) Ltd, Benrose, Johannesburg, South Africa), weighed on an electronic scale and anthropometric measurements were taken. Crown-rump length was measured with the baboons in the supine position on a calibrated ruler with a fixed head rest. Skinfold thicknesses were determined with a John Bull skinfold caliper (British Indicators Ltd, London) and circumferences with a steel tape. For skinfold and circumference measurements specific anatomical landmarks on the skeleton were identified to standardize the measurements. Thereafter, the baboons were anaesthetized with sodium pentobarbitone (1 mgkg; Sagatal@; Rh6ne-PouEnc, Pretoria, South Africa) given intravenously. A solution of 1 g glucose in 5 ml waterkg body weight was administered via a stomach tube. Venous blood samples were taken for the measurement of glucose, insulin, fibrinogen, PAI-1, albumin and lipids before the GTT and 30, 60, 90 and 120 min thereafter for the measurement of glucose and insulin. An intravenous catheter (Jelco, Johnson & Johnson, Halfway House, South Africa) was used. The catheter was placed in the vena cephalica. Blood (10 ml) for the preparation of serum was collected in the fasting state, and 5 ml at each time period during the GTT. Fasting citrate-treated plasma samples for the determination of fibrinogen concentration and PAI-1 activity were prepared by mixing one part of a buffered 0-1 mol sodium citrateA solution (cat. no. ORKH G98 01219; Behring, Marburg, Germany; pH 4 . 5 4 9 ) and nine parts of venous blood. Blood samples were centrifuged at 4000 rev./min within 15 min. Serum and plasma were stored in portions at -72" for later analyses. A balanced solution of electrolytes (Ringer's lactate equivalent, Plasmalyte B@ from Normosol R; Abbott Laboratories, Johannesburg, South Africa) was administered intravenously from the start of the GTT in order to perform 120 min GTT. Additional doses of pentobarbitone were necessary during the 2 h, but care was taken to keep the total amount the same for a particular baboon during the two GTT performed on each baboon. Finally, each baboon was given a lethal dose of pentobarbitone, livers were excised quickly, blotted dry and weighed. Samples were frozen in physiological saline (9g NaCVI) solution to prevent frost-bite and kept at -70" until analysed.
Serum and plasma analyses
Serum TC, TAG and glucose were determined using the SMACm Technicon AutoAnalyzer, (model SRA 2000; Technicon Instrument Co. Ltd, Tarry Town, NY, USA). The clinical chemistry methods of Technicon Instrument Co. Ltd were routinely used with observance of the standard quality-assurance measures. Serum HDL-cholesterol (HDL-C) and free fatty acid (FFA) were determined by enzymic colorimetric methods (cat. no. 263 869 and 1082 914 respectively; Boehringer Mannheim). Plasma fibrinogen concentration was determined by a modification of the method of Clauss (1957) using a Fibrintimer and reagents from Behring Institute (cat. no. OTXG 21; Marburg, Germany). PAI-1 activity was measured by an indirect enzymic method (Spectrolyse'@/pl PAI, cat. no. 101201; Biopool, UmeH, Sweden). The appropriate internal and external standards were used in all instances. The CV of repeated PAI-1 measurements was 3.5%. Serum insulin levels were determined using a radioimmunological kit (Phadeseph; Pharmacia Diagnostics AB, Uppsala, Sweden). Insulin sensitivity index was calculated as the reciprocal of fasting insulin x glucose multiplied by 10000 (Donahue et al. 1988) . The incremental glucose area above the fasting or other lowest value observed during the GTT was calculated. 
Liver analysis
The liver samples were stored at -70" until analysed. After the samples were thawed, portions of the liver were snap-frozen with liquid N2 and immediately ground to a fine powder, and weighed for protein and lipid analysis (Smuts et al. 1992) . For lipid extraction, the tissue was first suspended in 0.5 ml saline and extracted with chloroform-methanol (2: 1, v/v; Folch et al. 1957) containing butylated hydroxytoluene (0.1 ml/l) as antioxidant. A portion of the lipid extraction was then used for fatty acid, cholesterol, TAG and total phospholipid analysis.
The lipid extracts were fractionated by TLC as described by The spots corresponding to TAG and total phospholipids were marked, scraped off and transferred to glass-stoppered tubes. Fatty acids were transmethylated with 2.5 ml methanol-1 1.6 M-sulfuric acid (955, v/v) at 70" for 2 h, as described by Smuts et al. (1992) . The resultant fatty acid methyl esters were analysed using a Varian model 3700 gas chromatograph (Varian, Palo Alto, CA, USA) using fused silica megabore DB-225 columns (cat. no. 125-2232; J&W Scientific, Folsom, CA, USA). The individual fatty acid methyl esters were identified by comparison of the retention times with those of a standard mixture of FFA C14:o to C22:6.
The total phospholipid concentrations were determined colorimetrically with malachite green dye (Itaya & Ui, 1966) after digestion with perchloric acid (16 M) at 170" for 2h.
Lipid extracts were emulsified with peroxide-free Triton X100, as described by Smuts et al. (1992) , before analysis. TC and unesterified cholesterol from the emulsified lipid extracts were determined by an enzymic iodide method using cholesterol oxidase (EC 1 .I .3.6) and cholesterol esterase (EC 3.1.1.13) enzymic preparations. The concentration of cholesteryl ester (CE) was obtained by subtraction. The TAG concentrations were measured by an enzymic colorimetric method (Peridochrom GPO-PAP, cat. no. 701 882; BM, Germany).
The powdered liver preparations (10-15 mg) were first digested with NaOH and SDS at 37". The protein content was determined using a modification of the Lowry method (Markwell et al. 1978) .
Phospholipid determination.
Cholesterol and triacylglycerol determinations.
Protein determination.
Statistical analysis
Significant differences between groups were determined using Student-Newman-Keuls and Tukey tests (ANOVA, general linear model). Within groups, between baseline and final values, differences were analysed using paired Student's t tests. Pearson correlation coefficients were also calculated. All analyses were done using Statsoft@ CSS: Statistica software (Statsoft Inc., 1996) . P < 0.05 was considered significant.
RESULTS
The addition of SFC made no difference to the acceptability of the diet and caused no side effects. Mean energy intake of the baboons in group 2 (SFC) was 184.9 H k g body weight. However, the bitter taste of BF in the sandwiches resulted in reduced intake. Of the sandwiches offered to the baboons 62% were consumed. Consequently, the mean BF intake was only 4.2 mgkg. Fruit, shortbread and chocolate were accepted very well, and the dog biscuits fairly well. Mean daily energy intake of the baboons in group 1 (BF) was 175-8 kJ/ kg. The mean weight of the baboons increased somewhat, as shown in Table 1 . The mean increase of 1.3 kg in group 2 was statistically significant. However, the mean weight of the two groups did not differ from each other. Waist:hip increased in group 1 as result of a decrease in hip circumference. The subscapular skinfold thickness, which also correlates with android obesity (Donahue et al. 1987) , increased significantly in both groups.
The mean serum TC and LDL-C concentrations of both groups were significantly (P < 0.05) raised by the Westernized diet relative to the low-fat, high-fibre diet fed during the stablilizing period, while the concentration of TAG remained constant in group 2 but decreased significantly (P < 0-05) in group 1 from a mean pre-study value of 0.81 (SD 0.41) to 0.53 (SD 0.19) mmol/l. After 8 weeks of supplementation with SFC and BF, the mean serum TC concentration was significantly lower in both groups (Table 3 ). The LDL-C concentration followed the same pattern, but the changes were not significant. There was a significant decrease in the HDL-C concentration in the baboons fed on SFC, but the percentage of TC as HDL-C in both groups was higher than baseline value (P < 0.05 in group 1). The mean TAG concentration remained the same in group 2. However, an unexpected statistically significant increase in TAG was observed in group 1, the same baboons in which the Westernized stabilizing diet resulted in a decrease in TAG levels. SFC supplementation resulted in significantly lower FFA levels. In both groups, the albumin concentration increased, although the increase was not significant.
As shown in Table 3 , the mean PAI-1 activity was significantly reduced in the SFCsupplemented group but increased by BF (not significant). Plasma fibrinogen concentration remained remarkably constant during the stabilizing phase as well as during the experimental phase. The increase in albumin resulted in an increase in the albumin : fibrinogen value in both groups. It has been shown that low albumin levels affect the fibrinolytic system by modifying fibrin clot structure (Grandrille & Aiach, 1990) . No significant changes due to the different treatments were observed in fasting serum glucose or insulin, maximum increments in glucose or insulin during the 2 h GTT, calculated insulin sensitivity index and area under the glucose and insulin curves (Fig. 1) . There was considerable inter-individual variation in serum insulin levels. We have previously noted this variation in serum insulin levels among baboons (Venter et al. 1990) and are now reconsidering the suitability of the baboon for studies of glucose metabolism. In the present study, the mean baseline fasting serum insulin concentration as well as the maximum insulin increment of the BF-treated group was almost double that of the SFCsupplemented group (1 121 (SD 573) pmoM v. 639 (SD 398) pmoM and 990 (SD 796) pmoM v. 509 (SD 481) pmoM respectively; P < 0.05). In the BF-treated group, the area under the glucose curve did not change (baseline 11.5 (SD 8.6) mmoVl per min and final value 11.9 (SD 9.0) mmoM per min) whilst the area under the insulin curve decreased remarkably (1051 (SD 716) pmoM per min v. 690 (SD 713) pmoM per min) and the calculated insulin sensitivity index improved from 2.0 (SD 0-9) to 2.3 (SD 1-4) (not significant). In the SFCsupplemented group, the area under the glucose curve increased from 7.9 (SD 4-7) to 10.1 (SD 9.8) mmoM per min but the area under the insulin curve remained constant (baseline 572 (SD 460) and final 518 (SD 561) pmoM per min) and insulin sensitivity index decreased
The liver concentrations of TAG, cholesterol and phospholipids were lower (not significant) in the group which received BF than in the SFC supplemented group (86-2 (SD 60.7), 30.4 (SD 5-7) and 317.9 (SD 40.5) mg/g protein v. 122.1 (SD 100.7), 33.1 (SD 3.4) and 340 (SD 36.1) mg/g protein respectively). The only significant difference between the two groups was in the amount of docosahexaenoic acid (C22:6), which was higher in group 1 (BF; 58 (SD 9) moVlOO mol total fatty acids in phospholipids) than in group 2 (SFC; 47 (SD 6) mol/100 mol total fatty acids in phospholipids). from 4.7 (SD 3.2) to 3.8 (SD 2.4).
DISCUSSION
Significant reductions in PAI-1 have been reported in healthy subjects after changing from a traditional Western diet to a low-fat, high-fibre (35-46 g NSP/4200 kJ) diet (Mehrabian et al. 1990) . Furthermore, supplementing the habitual diet of healthy volunteers with oat husk (Sundell & Rinby, 1993) or guar gum (Landin et al. 1992 ) decreased PAI-1 activity. KGM-supplements had the same effect in nephrectomized rats (Brown et al. 1995) . The mechanism whereby the gel-fibre supplement used in the present study (a mixture of glucomannan, pectin and agar) decreased PAI-1 activity is not clear. PAI-1 activity has been shown to be positively correlated with insulin concentrations and degree of insulin resistance (Landin et al. 1990b) . Soluble NSP improves insulin sensitivity in diabetic patients (Koepp & Hegewisch, 1981; Vorster et al. 1988) , healthy men (Landin et al. 1992) and nephrectomized Sprague-Dawley rats (Brown et al. 1995) . However, insulin sensitivity in baboons was not improved by the SFC in the present study and could not have been the reason for the decrease in PAI-1 activity. The positive correlation between PAI-1 and serum TAG concentration which has been reported repeatedly (Mehta et al. 1987) , was not observed in our study. However, liver TAG concentration of the baboons was positively correlated with PAI-1 activity ( P < 0.05, r 0.7). Modest weight loss reduces PAI-1 levels (Sundell et al. 1989) , but the mean body weight of the baboons was significantly increased by the SFC-supplemented diet.
Very little is known about the influence of diet on coagulation and fibrinolysis. Studies done in hospitals in the UK showed that the incidence of post-operative venous thrombosis could be reduced by feeding patients high-NSP diets (Frohn, 1976; Latto, 1976) . Simpson et al. (1982) reported improvement in some coagulation factors in diabetic subjects who increased their intake of NSP, mainly as leguminuous vegetables. They failed to demonstrate an effect on fibrinogen levels. However, Koepp & Hegewisch (1981) reported decreased plasma viscosity and fibrinogen levels in diabetic children after supplementation of their diet with guar gum. Supplementing a Westernized diet fed to baboons with KGM lowered fibrinogen and factor X concentrations (Vorster et al. 1985) . Guar gum and KGM are both water-soluble NSP which are readily fermented by bacteria in the large gut to the short-chain fatty acids (SCFA) acetic, propionic and butyric acid.
The possibility that SCFA may have an inhibitory effect on blood coagulation was first mentioned by Malhotra (1968) , an Indian physician who found longer mean clotting time and softer, jelly-like clots in men in Udaipur, North India, in comparison with men in Madras in South India who ate less cellulose and vegetable fibres.
The mechanism whereby SCFA may influence the coagulation system is not clear. Studies in human subjects indicate that acetate, the major SCFA produced in the colon, passes to peripheral tissues, where it is metabolized by muscle (Cummings et al. 1988) . Butyrate is largely taken up by colonic epithelial cells and propionate is cleared by the liver. Reeder et al. (1993) demonstrated in vitro that sodium butyrate alters the balance of components of the plasminogen activator system favourably . It is further possible that by stimulating glycolysis (Anderson & Bridges, 1984) and inhibiting the release of fatty acids (Chen et al. 1984) , propionate may inhibit the synthesis of fibrinogen and other coagulation factors in the liver. Pilgeram & Pickart (1968) suggested that raised circulating FFA levels stimulate fibrinogen synthesis. In the present study, the mean fibrinogen concentration decreased by 5% in both groups but the change was not significant. The BF dose could have been too small to be effective. However, the amount of SFC fed to the baboons in the present study was the same as that used in the previous study (Vorster et al. 1985) . Fibrinogen concentration of the baboons in the present study was in the normal range, which is probably difficult to improve. Although not statistically significant, serum albumin concentration increased in both groups, resulting in a higher a1bumin:fibrinogen value. As mentioned earlier, low albumin concentrations may alter the structure of fibrin clots and reduce thrombolysis (Gandrille & Aiach, 1990) . Khodabandehlou & Le Devehat (1990) suggested that the a1bumin:fibrinogen value indicates the erythrocyte aggregation tendency and, therefore, the haemorheological risk.
BF is an effective lipid-lowering agent in human subjects as well as in animal models (Stahlberg, 1992) . The recommended dosage of the sustained formulation is 400 mg/d (6.7 mgkg for an adult weighing 60 kg). The same dose was given to the baboons. However, because of the bitter taste the mean intake was only 4.2 mgkg body weight per d. Marked species differences between rats, mice, guinea-pigs, hamsters, rabbits, dogs and monkeys in hepatic response to BF have been reported (Watanabe et al. 1989) . Compared with the 10 mgkg body weight perd administered intragastrically by Stegmeier et al. (1980) to normolipidaemic non-human primates, the dose in our study might have been too small to lower TAG. A significant dose-response relationship for plasma cholesterol and TAG concentrations has been reported for BF (Stahlberg, 1992) .
The present study showed that 4.2 mg BFkg body weight daily for 8 weeks reduced serum TC and LDL-C concentrations by 11% ( P < 0.05) and 13% (not significant) respectively in baboons. HDL-C tended to be lower than baseline values and serum TAG rose significantly, but liver lipid concentration tended to be lower in BF-treated animals than in the group fed on SFC. The availability of fatty acids has a strong influence on the rate of TAG and VLDL production by the liver (Kissebah et al. 1974; Catapano 1992) . However, Karhapaa et al. (1992) reported no change in FFA levels during BF treatment of patients with combined hyperlipidaemia. In contrast to the inability of BF to change fasting serum FFA in the baboons, SFC supplementation reduced FFA markedly ( P < 0.05), an effect which has previously been observed in baboons (Venter et al. 1990 ). The hypocholesterolaemic effect of soluble dietary fibres, as observed in the present study, is well known (Arvill & Boden, 1995) . However, SFC had no beneficial effect on indices of glucose metabolism in the baboons. Although insulin sensitivity was improved to some extent by BF, and insulin response during the GTT reduced, we did not notice any significant changes in indices of glucose metabolism. Therefore, our findings suggest that low doses of BF do not change insulin sensitivity in baboons. Karhapaa et al. (1992) came to the same conclusion with regard to insulin sensitivity in subjects with combined hyperlipidaemia and normal glucose tolerance.
In conclusion, both interventions had beneficial effects on the CHD risk profile in the baboon model, whilst the SFC had more pronounced effects. It seems that the effects of BF were mediated through the liver. It is recommended that subjects at risk of developing CHD and patients with confirmed CHD (with the exception of familial hypercholesterolaemia) should increase their intake of soluble NSP before medication is considered. No side effects were observed in the baboons fed on SFC; on the contrary, the increases in body weight and in daily energy intake from the diet were somewhat higher than those in the BF-supplemented group. NSP concentrates may be used effectively in the treatment of the metabolic syndrome associated with android obesity. However, the effect of SFC on haemostatic balance needs to be confirmed and possible mechanisms need to be identified.
